Overview

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414

Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and Food Effects of DA414 Granules in Chinese healthy subjects with single and multiple doses.
Phase:
PHASE1
Details
Lead Sponsor:
Chendu DIAO Nine Hong Pharmaceutical Factory